Prestige Consumer Healthcare Sets Annual Meeting, Elects Directors
Prestige Consumer Healthcare Inc. announced its 2026 Annual Meeting of Stockholders for August 4, 2026, where shareholders will vote on the election of six directors, an advisory resolution on executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent auditor. Director Sheila A. Hopkins will retire from the Board, reducing its size to six members. The company also highlighted its Fiscal 2026 performance, reporting $1,089 million in revenue, $4.38 Adjusted Diluted EPS (down 3%), and approximately $246 million in Free Cash Flow, which enabled the fiscal 2027 acquisition of Breathe Right®.
Key Highlights
- Annual Meeting of Stockholders scheduled for August 4, 2026, at 10:00 a.m. EDT.
- Record date for voting at the Annual Meeting is June 10, 2026.
- Shareholders will vote to elect six directors to the Board.
- Director Sheila A. Hopkins will retire, reducing the Board to six members.
- Advisory vote to approve named executive officer compensation will be held.
- Shareholders will ratify PricewaterhouseCoopers LLP as auditor for FY2027.
- Fiscal 2026 revenue was $1,089 million.
- Fiscal 2026 Adjusted Diluted EPS was $4.38, down approximately 3%.
Price Impact
More from PBH
Prestige Consumer Healthcare Executives to Present at Canaccord Conference
Prestige Consumer Healthcare Acquires OTC Wellness Business for $1.045B
Prestige Consumer Raises FY27 Outlook on Acquisitions; Q1 Revenue $265.7M